MED22 Antikörper (full length)
Kurzübersicht für MED22 Antikörper (full length) (ABIN7878593)
Target
Alle MED22 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- MED22 Antibody
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the MED22 antibody.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal dilution of the MED22 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the MED22 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- MED22 (Mediator Complex Subunit 22 (MED22))
-
Andere Bezeichnung
- MED22
-
Hintergrund
- Med22 is a subunit of the RNA polymerase II (Pol II) transcriptional mediator complex. The mediator complex is a coactivator involved in the regulated transcription of Pol II-dependent genes. Functioning as a bridge to convey information from gene-specific regulatory proteins to the basal Pol II transcription machinery, the mediator complex is recruited to promoter regions by directly interacting with regulatory proteins. The mediator complex also serves as a scaffold for the assembly of a functional pre-initiation complex with Pol II and other general transcription factors. Med22 (mediator complex subunit 22), also known as SURF5 (surfeit locus protein 5), is a ubiquitously expressed 200 amino acid nuclear protein that is one of several components of the mediator complex. There are two isoforms of Med22 that are produced as a result of alternative splicing events.
-
UniProt
- Q15528
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-